Clinical Trials Directory

Trials / Unknown

UnknownNCT05277090

Bowel Preparation May Lead to a Higher Feasibility of Intestinal Infection

Bowel Preparation for Colonoscopy May Lead to a Higher Feasibility of Intestinal Infection: a Clinical and Basic Research

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Yanqing Li · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

An adequate bowel preparation is essential for a high quality of colonscopy. Nowdays, polyethyleneglyco is considered the most safe drug for bowel preparation, and is widely used around the world. However, previous study illustrated that bowel preparation by polyethyleneglyco could lead to qualitative changes in the intestinal microbiota both in mice and human. This study is aimed to investigate wether the changes in the intestinal microbiota could lead to a higher rate of intestinal infection.

Conditions

Interventions

TypeNameDescription
DRUG2L of polyethyleneglycol2L of polyethyleneglycol
DIETARY_SUPPLEMENTinulin15g inulin per day
COMBINATION_PRODUCTprobiotic combination productparticipants take 2L of polyethyleneglycol, subsequently take 15g probiotics combination product (including Bifidobacterium lactis, Lactobacillus plantarum, inlulin, Vitamin C) per day. The probiotic combination product, named "Mei Ri Yi Jun" was produced by Wedge Pharmaceuticals.

Timeline

Start date
2022-03-15
Primary completion
2022-03-15
Completion
2022-03-15
First posted
2022-03-14
Last updated
2022-03-14

Source: ClinicalTrials.gov record NCT05277090. Inclusion in this directory is not an endorsement.